Suppr超能文献

在肺动脉高压中,炎性巨噬细胞的扩张依赖于血液来源的单核细胞的动员。

Inflammatory Macrophage Expansion in Pulmonary Hypertension Depends upon Mobilization of Blood-Borne Monocytes.

机构信息

Center for Pulmonary Vascular Biology and Medicine, Pittsburgh Heart, Lung, Blood, and Vascular Medicine Institute, Division of Cardiology, Department of Medicine, University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15213.

Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15213.

出版信息

J Immunol. 2018 May 15;200(10):3612-3625. doi: 10.4049/jimmunol.1701287. Epub 2018 Apr 9.

Abstract

Pulmonary inflammation, which is characterized by the presence of perivascular macrophages, has been proposed as a key pathogenic driver of pulmonary hypertension (PH), a vascular disease with increasing global significance. However, the mechanisms of expansion of lung macrophages and the role of blood-borne monocytes in PH are poorly understood. Using multicolor flow cytometric analysis of blood in mouse and rat models of PH and patients with PH, an increase in blood monocytes was observed. In parallel, lung tissue displayed increased chemokine transcript expression, including those responsible for monocyte recruitment, such as and , accompanied by an expansion of interstitial lung macrophages. These data indicate that blood monocytes are recruited to lung perivascular spaces and differentiate into inflammatory macrophages. Correspondingly, parabiosis between congenically different hypoxic mice demonstrated that most interstitial macrophages originated from blood monocytes. To define the actions of these cells in PH in vivo, we reduced blood monocyte numbers via genetic deficiency of or in chronically hypoxic male mice and by pharmacologic inhibition of Cxcl1 in monocrotaline-exposed rats. Both models exhibited decreased inflammatory blood monocytes, as well as interstitial macrophages, leading to a substantial decrease in arteriolar remodeling but with a less robust hemodynamic effect. This study defines a direct mechanism by which interstitial macrophages expand in PH. It also demonstrates a pathway for pulmonary vascular remodeling in PH that depends upon interstitial macrophage-dependent inflammation yet is dissociated, at least in part, from hemodynamic consequences, thus offering guidance on future anti-inflammatory therapeutic strategies in this disease.

摘要

肺炎症,其特征在于存在血管周围巨噬细胞,已被提出作为肺动脉高压(PH)的关键致病驱动因素,肺动脉高压是一种具有日益重要的全球意义的血管疾病。然而,肺巨噬细胞扩张的机制以及血液单核细胞在 PH 中的作用仍知之甚少。通过对 PH 小鼠和大鼠模型以及 PH 患者的血液进行多色流式细胞术分析,观察到血液单核细胞增加。与此同时,肺组织显示趋化因子转录表达增加,包括负责单核细胞募集的趋化因子,如 和 ,同时伴有间质肺巨噬细胞扩张。这些数据表明血液单核细胞被募集到肺血管周围空间,并分化为炎症性巨噬细胞。相应地,在缺氧的同基因不同小鼠之间的联体共生实验表明,大多数间质巨噬细胞来源于血液单核细胞。为了在体内定义这些细胞在 PH 中的作用,我们通过在慢性缺氧的雄性小鼠中遗传缺失 或 以及在暴露于单硝酸异山梨酯的大鼠中抑制 Cxcl1 来减少血液单核细胞数量。这两种模型均显示出炎症性血液单核细胞和间质巨噬细胞减少,导致小动脉重塑显著减少,但血流动力学效应较弱。这项研究定义了 PH 中间质巨噬细胞扩张的直接机制。它还证明了 PH 中肺血管重塑的途径,该途径依赖于间质巨噬细胞依赖性炎症,但至少在一定程度上与血流动力学后果分离,从而为该疾病的未来抗炎治疗策略提供了指导。

相似文献

1
Inflammatory Macrophage Expansion in Pulmonary Hypertension Depends upon Mobilization of Blood-Borne Monocytes.
J Immunol. 2018 May 15;200(10):3612-3625. doi: 10.4049/jimmunol.1701287. Epub 2018 Apr 9.
2
Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2017 May;56(5):597-608. doi: 10.1165/rcmb.2016-0201OC.
3
Heterogeneity of lung mononuclear phagocytes during pneumonia: contribution of chemokine receptors.
Am J Physiol Lung Cell Mol Physiol. 2013 Nov 15;305(10):L702-11. doi: 10.1152/ajplung.00194.2013. Epub 2013 Sep 20.
5
Molecular imaging of folate receptor β-positive macrophages during acute lung inflammation.
Am J Respir Cell Mol Biol. 2015 Jul;53(1):50-9. doi: 10.1165/rcmb.2014-0289OC.
6
Gas6 Promotes Inflammatory (CCR2CX3CR1) Monocyte Recruitment in Venous Thrombosis.
Arterioscler Thromb Vasc Biol. 2017 Jul;37(7):1315-1322. doi: 10.1161/ATVBAHA.116.308925. Epub 2017 Apr 27.
7
Nonclassical Monocytes Sense Hypoxia, Regulate Pulmonary Vascular Remodeling, and Promote Pulmonary Hypertension.
J Immunol. 2020 Mar 15;204(6):1474-1485. doi: 10.4049/jimmunol.1900239. Epub 2020 Jan 29.
8
CCR2-positive monocytes recruited to inflamed lungs downregulate local CCL2 chemokine levels.
Am J Physiol Lung Cell Mol Physiol. 2005 Feb;288(2):L350-8. doi: 10.1152/ajplung.00061.2004. Epub 2004 Oct 29.
10
Interstitial macrophage phenotypes in -induced pulmonary hypertension.
Front Immunol. 2024 May 8;15:1372957. doi: 10.3389/fimmu.2024.1372957. eCollection 2024.

引用本文的文献

1
Biomarkers in COPD-Associated PH/CCP: Circulating Molecules and Cell-Intrinsic Marker.
Int J Chron Obstruct Pulmon Dis. 2025 Aug 15;20:2869-2883. doi: 10.2147/COPD.S521659. eCollection 2025.
2
Microbiota Transplant Therapy Is Safe and Feasible in Pulmonary Arterial Hypertension.
JACC Basic Transl Sci. 2025 Aug 12;10(9):101347. doi: 10.1016/j.jacbts.2025.101347.
3
HNRNPA2B1: a novel target in pulmonary arterial hypertension.
Front Cardiovasc Med. 2025 Jul 9;12:1497938. doi: 10.3389/fcvm.2025.1497938. eCollection 2025.
4
Hydrogen sulfide as a new therapeutic target of pulmonary hypertension: an overview with update on immunomodulation.
Front Pharmacol. 2025 May 12;16:1510275. doi: 10.3389/fphar.2025.1510275. eCollection 2025.
5
Epigenetic Control of Alveolar Macrophages: Impact on Lung Health and Disease.
Cells. 2025 Apr 25;14(9):640. doi: 10.3390/cells14090640.
8
Monocytes and interstitial macrophages contribute to hypoxic pulmonary hypertension.
J Clin Invest. 2025 Jan 30;135(6):e176865. doi: 10.1172/JCI176865.
10
Reversal of inflammatory reprogramming by vasodilator agents in pulmonary hypertension.
ERJ Open Res. 2025 Jan 13;11(1). doi: 10.1183/23120541.00486-2024. eCollection 2025 Jan.

本文引用的文献

1
Relationship between portopulmonary hypertension and splenectomy: Mayo Clinic experience and review of published works.
Hepatol Res. 2018 Feb;48(3):E340-E346. doi: 10.1111/hepr.12930. Epub 2017 Aug 31.
2
Risk of cardiovascular events and pulmonary hypertension following splenectomy - a Danish population-based cohort study from 1996-2012.
Haematologica. 2017 Aug;102(8):1333-1341. doi: 10.3324/haematol.2016.157008. Epub 2017 Jun 1.
4
A Time- and Compartment-Specific Activation of Lung Macrophages in Hypoxic Pulmonary Hypertension.
J Immunol. 2017 Jun 15;198(12):4802-4812. doi: 10.4049/jimmunol.1601692. Epub 2017 May 12.
5
Amphetamines promote mitochondrial dysfunction and DNA damage in pulmonary hypertension.
JCI Insight. 2017 Jan 26;2(2):e90427. doi: 10.1172/jci.insight.90427.
6
Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2017 May;56(5):597-608. doi: 10.1165/rcmb.2016-0201OC.
7
Hematological disorders and pulmonary hypertension.
World J Cardiol. 2016 Dec 26;8(12):703-718. doi: 10.4330/wjc.v8.i12.703.
8
Deleting an Nr4a1 Super-Enhancer Subdomain Ablates Ly6C Monocytes while Preserving Macrophage Gene Function.
Immunity. 2016 Nov 15;45(5):975-987. doi: 10.1016/j.immuni.2016.10.011. Epub 2016 Nov 1.
10
Developmental origin of lung macrophage diversity.
Development. 2016 Apr 15;143(8):1318-27. doi: 10.1242/dev.129122. Epub 2016 Mar 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验